Delivery Order SPE2DB20D1050-SPE2DB24FH87Y
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COPAXONE 40 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,095.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of COPAXONE 40 MG/ML SYRINGE to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,053.55 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of COPAXONE 40 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The $1,583.28 Firm Fixed Price delivery order was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024 with an ultimate completion date of October 21, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is a delivery order for COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of COPAXONE 40 MG/ML syringes to the Medical Supply Chain, a unit of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $8,925.37. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery...
This federal contract award is for the delivery of COPAXONE 40 MG/ML syringes to the U.S. Defense agency, the Medical Supply Chain division. The $2,030.40 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of May 7, 2024. Amerisourcebergen also holds two Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA) Troop Support Medical and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $1,092.00 and a completion date of April 2, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.00 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a $6,552 firm-fixed-price delivery order for COPAXONE 40 MG/ML SYRINGE. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,964.56 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML syringes, with a completion date of June 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive...